National Facilitators and Barriers to the Implementation of Incentives for Antibiotic Access and Innovation
Prominent reports have assessed the challenges to antibiotic innovation and recommended implementing "pull" incentives, i.e., mechanisms that give increased and predictable revenues for important, marketed antibiotics. We set out to understand countries' perceptions of these recommend...
Wedi'i Gadw mewn:
Prif Awduron: | Christine Årdal (Awdur), Yohann Lacotte (Awdur), Suzanne Edwards (Awdur), Marie-Cécile Ploy (Awdur), on behalf of the European Union Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections (EU-JAMRAI) (Awdur) |
---|---|
Fformat: | Llyfr |
Cyhoeddwyd: |
MDPI AG,
2021-06-01T00:00:00Z.
|
Pynciau: | |
Mynediad Ar-lein: | Connect to this object online. |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Eitemau Tebyg
-
Linking sustainable use policies to novel economic incentives to stimulate antibiotic research and development
gan: Ursula Theuretzbacher, et al.
Cyhoeddwyd: (2017) -
Characterization of Carbapenemase- and ESBL-Producing Gram-Negative Bacilli Isolated from Patients with Urinary Tract and Bloodstream Infections
gan: Isabella A. Tickler, et al.
Cyhoeddwyd: (2023) -
The Treaty of the European Union, Maastricht Treaty, 7th February, 1992
gan: European Union -
Educating, training, and exercising for infectious disease control with emphasis on cross-border settings: an integrative review
gan: Doret de Rooij, et al.
Cyhoeddwyd: (2020) -
Assessing training needs in infectious disease management at major ports, airports and ground-crossings in Europe
gan: Doret de Rooij, et al.
Cyhoeddwyd: (2021)